Global issues in drug development for Alzheimer’s disease

Abstract The number of clinical trials for Alzheimer’s disease conducted outside the United States in a broad array of countries is increasing. As the number of compounds ready for clinical testing increases, and as trials become longer and more complex, this trend is expected to grow. The cultural...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2011-03, Vol.7 (2), p.197-207
Hauptverfasser:	Doody, Rachelle S, Cole, Patricia E, Miller, David S, Siemers, Eric, Black, Ronald, Feldman, Howard, Schindler, Rachel, Graham, Stephen, Heath, Theresa, Khachaturian, Ara S, Evans, Rebecca, Carrillo, Maria C
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer's disease Clinical trials Clinical Trials as Topic Congresses as Topic Critical incidents Drug Discovery Global perspective Humans National identity Neurology Regional variations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!